Add to ORKGA double-blind placebo-controlled trial was conducted, involving 97 obese diabetic and glucose intolerant patients receiving either 60 mg fluoxetine daily (47 patients) or a placebo (50 patients); a similar calorie-restricted diet was prescribed to all patients. Weight loss was significantly higher in the fluoxetine-treated patients, whose diabetic status improved. Drop-out rate was not significantly different for both groups of patients.SCOPUS: ar.jinfo:eu-repo/semantics/publishe
peer reviewedObesity is a well-known risk factor for non-insulin-dependent (or Type 2) diabetes mell...
Background: The number of gastric restrictive bariatric operations is increasing each year, but abou...
In this study the effect of fluoxetine versus placebo treatment on body weight, body composition and...
A double-blind placebo-controlled trial was conducted, involving 97 obese diabetic and glucose intol...
A double-blind placebo-controlled trial was conducted, involving 97 obese diabetic and glucose intol...
Weight reduction is essential in the management of most non-insulin-dependent diabetics, but this th...
Weight reduction is essential in the management of most noninsulin-dependent diabetics, but this the...
ABSTRACT Fluoxetine is a highly specific serotonin reup-take inhibitor. In studies that used a dose ...
BACKGROUND: The prevalence of obesity and diabetes is increasing dramatically throughout the world. ...
The effect of fluoxetine on body weight and spontaneous food choice was studied in twenty-three heal...
In this paper we investigated the effect of fluoxetine (60 mg/d) on serum lipids, glucose and insuli...
Fluoxetine (Prozac) use may result in an average, short-term weight loss of up to 3.3 kg (7 lb, 4 oz...
The prevalence of obesity and diabetes is increasing dramatically throughout the world. Studies have...
I investigated the effects of continuous administration of fluoxetine, a serotonin reuptake inhibito...
Our objective was to assess thermogenic action of fluoxetine (FL) in obese menopausal women, evaluat...
peer reviewedObesity is a well-known risk factor for non-insulin-dependent (or Type 2) diabetes mell...
Background: The number of gastric restrictive bariatric operations is increasing each year, but abou...
In this study the effect of fluoxetine versus placebo treatment on body weight, body composition and...
A double-blind placebo-controlled trial was conducted, involving 97 obese diabetic and glucose intol...
A double-blind placebo-controlled trial was conducted, involving 97 obese diabetic and glucose intol...
Weight reduction is essential in the management of most non-insulin-dependent diabetics, but this th...
Weight reduction is essential in the management of most noninsulin-dependent diabetics, but this the...
ABSTRACT Fluoxetine is a highly specific serotonin reup-take inhibitor. In studies that used a dose ...
BACKGROUND: The prevalence of obesity and diabetes is increasing dramatically throughout the world. ...
The effect of fluoxetine on body weight and spontaneous food choice was studied in twenty-three heal...
In this paper we investigated the effect of fluoxetine (60 mg/d) on serum lipids, glucose and insuli...
Fluoxetine (Prozac) use may result in an average, short-term weight loss of up to 3.3 kg (7 lb, 4 oz...
The prevalence of obesity and diabetes is increasing dramatically throughout the world. Studies have...
I investigated the effects of continuous administration of fluoxetine, a serotonin reuptake inhibito...
Our objective was to assess thermogenic action of fluoxetine (FL) in obese menopausal women, evaluat...
peer reviewedObesity is a well-known risk factor for non-insulin-dependent (or Type 2) diabetes mell...
Background: The number of gastric restrictive bariatric operations is increasing each year, but abou...
In this study the effect of fluoxetine versus placebo treatment on body weight, body composition and...